Clinical Research Directory
Browse clinical research sites, groups, and studies.
Predicting Cancer Risk With Digital and Molecular Markers
Sponsor: University of Erlangen-Nürnberg Medical School
Summary
The goal of this study is to identify new markers to predict the risk of developing cancer, primarily breast cancer. For this purpose, researchers will compare data obtained from cancer patients and healthy individuals. If characteristic differences are identified, e.g. in biomarkers, life style or family history, this may indicate a person's increased risk of developing cancer.
Official title: Digital and Molecular Detection of Markers for Disease Risk Prediction, Improvement of Diagnostic Detection Accuracy and Implementation for Preventive Measures of Cancer - A Combined Case-control and Cohort Study
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1250
Start Date
2024-09-14
Completion Date
2025-12
Last Updated
2025-05-08
Healthy Volunteers
Yes
Interventions
Biomaterial collection
All subjects will be asked to provide biomaterial (blood or saliva) for bio marker screening and analysis. Additional biomaterial (breath, urin, stool) is optional.
BayPass mobile application
All subjects will be asked to use the study-specific mobile application "BayPass" to complete questionnaires and provide results from screening examinations over a course of 12 months.
Locations (1)
DigiOnko Präventionsmobil
Please Refer to Project Homepage For Details (see Link Below), Bavaria, Germany